A detailed history of Janus Henderson Group PLC transactions in Glaukos Corp stock. As of the latest transaction made, Janus Henderson Group PLC holds 1,457,533 shares of GKOS stock, worth $190 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
1,457,533
Previous 1,610,888 9.52%
Holding current value
$190 Million
Previous $152 Million 13.57%
% of portfolio
0.09%
Previous 0.09%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$89.48 - $118.35 $13.7 Million - $18.1 Million
-153,355 Reduced 9.52%
1,457,533 $172 Million
Q1 2024

May 15, 2024

SELL
$76.4 - $96.33 $431,354 - $543,879
-5,646 Reduced 0.35%
1,610,888 $152 Million
Q4 2023

Feb 14, 2024

BUY
$59.53 - $85.11 $80,782 - $115,494
1,357 Added 0.08%
1,616,534 $128 Million
Q3 2023

Nov 14, 2023

SELL
$69.23 - $79.09 $264,735 - $302,440
-3,824 Reduced 0.24%
1,615,177 $122 Million
Q2 2023

Aug 14, 2023

BUY
$45.44 - $71.21 $1.66 Million - $2.61 Million
36,605 Added 2.31%
1,619,001 $115 Million
Q1 2023

May 15, 2023

BUY
$43.88 - $52.48 $502,513 - $601,000
11,452 Added 0.73%
1,582,396 $79.3 Million
Q4 2022

Feb 14, 2023

SELL
$40.82 - $57.75 $423,099 - $598,578
-10,365 Reduced 0.66%
1,570,944 $68.6 Million
Q3 2022

Nov 14, 2022

SELL
$46.84 - $58.49 $13.6 Million - $17 Million
-289,958 Reduced 15.5%
1,581,309 $84.2 Million
Q2 2022

Aug 15, 2022

BUY
$34.86 - $63.77 $41,762 - $76,396
1,198 Added 0.06%
1,871,267 $85 Million
Q1 2022

May 16, 2022

BUY
$44.33 - $57.82 $12.9 Million - $16.8 Million
290,043 Added 18.36%
1,870,069 $108 Million
Q4 2021

Feb 14, 2022

BUY
$40.27 - $56.99 $713,060 - $1.01 Million
17,707 Added 1.13%
1,580,026 $70.2 Million
Q3 2021

Nov 16, 2021

BUY
$47.43 - $84.23 $52,931 - $94,000
1,116 Added 0.07%
1,562,319 $75.3 Million
Q2 2021

Aug 16, 2021

BUY
$73.06 - $97.7 $6.96 Million - $9.3 Million
95,237 Added 6.5%
1,561,203 $132 Million
Q1 2021

May 17, 2021

SELL
$70.43 - $97.42 $6.32 Million - $8.74 Million
-89,685 Reduced 5.77%
1,465,966 $123 Million
Q4 2020

Feb 16, 2021

SELL
$48.9 - $75.26 $11.6 Million - $17.8 Million
-236,915 Reduced 13.22%
1,555,651 $117 Million
Q3 2020

Nov 16, 2020

BUY
$37.23 - $50.97 $2.42 Million - $3.32 Million
65,077 Added 3.77%
1,792,566 $88.8 Million
Q2 2020

Aug 14, 2020

SELL
$28.78 - $46.83 $19.2 Million - $31.2 Million
-666,431 Reduced 27.84%
1,727,489 $66.4 Million
Q1 2020

May 14, 2020

BUY
$25.53 - $70.14 $17.1 Million - $46.8 Million
667,947 Added 38.7%
2,393,920 $73.9 Million
Q4 2019

Feb 18, 2020

BUY
$54.18 - $65.64 $11.4 Million - $13.8 Million
209,827 Added 13.84%
1,725,973 $94 Million
Q3 2019

Nov 14, 2019

BUY
$58.58 - $83.91 $26.1 Million - $37.4 Million
445,332 Added 41.59%
1,516,146 $94.8 Million
Q2 2019

Jul 31, 2019

SELL
$63.59 - $78.71 $230,895 - $285,796
-3,631 Reduced 0.34%
1,070,814 $80.7 Million
Q1 2019

Apr 30, 2019

SELL
$50.75 - $80.54 $52.9 Million - $83.9 Million
-1,041,547 Reduced 49.22%
1,074,445 $84.2 Million
Q4 2018

Feb 06, 2019

SELL
$52.18 - $67.93 $53.3 Million - $69.4 Million
-1,021,881 Reduced 32.57%
2,115,992 $119 Million
Q3 2018

Nov 09, 2018

SELL
$38.13 - $68.37 $66.1 Million - $118 Million
-1,733,161 Reduced 35.58%
3,137,873 $204 Million
Q2 2018

Aug 10, 2018

SELL
$27.62 - $44.51 $5.81 Million - $9.37 Million
-210,405 Reduced 4.14%
4,871,034 $198 Million
Q1 2018

May 14, 2018

SELL
$26.05 - $34.5 $446,809 - $591,744
-17,152 Reduced 0.34%
5,081,439 $157 Million
Q4 2017

Feb 09, 2018

BUY
$24.5 - $36.01 $43 Million - $63.2 Million
1,754,230 Added 52.45%
5,098,591 $131 Million
Q3 2017

Nov 14, 2017

BUY
$31.26 - $42.03 $7.04 Million - $9.46 Million
225,105 Added 7.22%
3,344,361 $0
Q2 2017

Aug 17, 2017

BUY
N/A
3,119,256
3,119,256 $129 Million

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $6.19B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.